Penmenvy combines the antigenic components of Bexsero (meningococcal Group B vaccine) and Menveo (meningococcal Groups A, C, Y, and W-135 oligosaccharide diphtheria CRM197 conjugate vaccine).

A global biopharma is fighting malaria in endemic countries through partnerships that harness R&D, broaden access to ...

The role of insects in drug discovery is expanding, with biopharmaceuticals derived from insect cells offering sustainable solutions for medical applications.

Zostavax and Shingrix are linked to protection for older adults in multiple studies.

A new study is part of a growing body of evidence that vaccination against shingles—and potentially other infections—can be protective against developing dementia. While there is currently no ...

Global biopharma company GSK has awarded nearly $2 million in funding through its COiMMUNITY Initiative grant program to 15 organizations focused on improving adult immunization across the ...

GlaxoSmithKline recently held a high-level scientific conference in conjunction with the launch of “Bexsero,” the first vaccine in Egypt approved by the Egyptian Drug Authority for the ...

Korea GSK announced on the 10th that it has selected actress Lee Jung-hyun as the official model for its new advertising campaign for the only domestic meningococcal B vaccine 'Bexsero ...

The flu vaccine is recommended annually for all Americans 6 months and older, per the Centers for Disease Control and Prevention — but a new study from Cleveland Clinic suggests that it might ...

"We encourage people to get the measles vaccine," Kennedy told CBS News chief medical correspondent Dr. Jon LaPook on Tuesday during his Make America Healthy Again tour in Arizona, marking the ...

Recall the Comirnaty® and Spikevax® mRNA-based vaccines each utilize lipid nanoparticles ... the Netherlands, and Belgium from 2022 to 2023. CureVac v. Pfizer+BioNTech In June 2022, longstanding ...